Accuray Incorporated logo
Accuray Incorporated ARAY
$ 0.41 -0.91%

Annual report 2025
added 02-17-2026

report update icon

Accuray Incorporated Balance Sheet 2011-2026 | ARAY

Annual Balance Sheet Accuray Incorporated

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

73.7 M 102 M 86.3 M 90.3 M 60 M 87.6 M 83 M 48 M 92.5 M 90.6 M 123 M 103 M 125 M -64 M -95.9 M

Long Term Debt

124 M 164 M 172 M 172 M 170 M 189 M 160 M 131 M 51.5 M 171 M 203 M 196 M 199 M 79.5 M -

Long Term Debt Current

7.38 M 6.22 M 4.15 M 8.57 M 8.17 M 8.22 M - - 113 M 39.9 M - - - - -

Total Non Current Liabilities

- - - - - - 196 M 161 M 75.4 M 199 M 224 M 212 M 213 M 95.1 M 12.4 M

Total Current Liabilities

193 M 195 M 199 M 209 M 192 M 182 M 192 M 169 M 284 M 210 M 170 M 185 M 156 M 174 M -

Total Liabilities

389 M 424 M 426 M 420 M 411 M 427 M 388 M 330 M 360 M 409 M 394 M 397 M 369 M 269 M 215 M

Deferred Revenue

82.3 M 71.6 M 72.2 M 75.4 M 81.7 M 106 M 98.7 M 98.3 M 105 M 114 M 116 M 112 M 105 M 101 M 94 M

Retained Earnings

-519 M -518 M -502 M -493 M -488 M -482 M -486 M -474 M -450 M -421 M -395 M -355 M -320 M -216 M -144 M

Total Assets

470 M 469 M 479 M 473 M 480 M 491 M 438 M 379 M 406 M 469 M 470 M 495 M 476 M 473 M 456 M

Cash and Cash Equivalents

57.4 M 68.6 M 89.4 M 90.2 M 118 M 110 M 76.8 M 83.1 M 72.1 M 120 M 79.6 M 92.3 M 73.3 M 144 M 95.9 M

Book Value

81.2 M 45.1 M 53.7 M 53.2 M 68.8 M 63.6 M 49.9 M 48.6 M 46.5 M 59.7 M 75.8 M 98.5 M 107 M 204 M 240 M

Total Shareholders Equity

81.2 M 45.1 M 53.7 M 53.2 M 68.8 M 63.6 M 49.9 M 48.6 M 46.5 M 59.7 M 75.8 M 98.5 M 107 M 204 M 230 M

All numbers in USD currency

Quarterly Balance Sheet Accuray Incorporated

2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

125 M 127 M 124 M 166 M 168 M 162 M 164 M 166 M 168 M 170 M 172 M 173 M 174 M 171 M 172 M 173 M 174 M 194 M 170 M 170 M 168 M 174 M 189 M 189 M 184 M 188 M 160 M 160 M 137 M 129 M 131 M 131 M 130 M 119 M 51.5 M 51.5 M 167 M 172 M 171 M 171 M 110 M 110 M 200 M 203 M 199 M 197 M 196 M 196 M 201 M 200 M 199 M 199 M 81.6 M 80.5 M 79.5 M 79.5 M 77.5 M 76.6 M - -

Total Liabilities

395 M 395 M 389 M 435 M 430 M 428 M 424 M 421 M 429 M 426 M 426 M 421 M 417 M 419 M 420 M 418 M 425 M 430 M 411 M 411 M 400 M 397 M 427 M 427 M 423 M 423 M 388 M 388 M 340 M 322 M 330 M 330 M 365 M 345 M 360 M 360 M 369 M 369 M 409 M 409 M 412 M 398 M 391 M 394 M 392 M 379 M 397 M 397 M 390 M 378 M 369 M 369 M 265 M 269 M 269 M 269 M 261 M 261 M 215 M 215 M

Deferred Revenue

79 M 79.6 M 82.3 M 81.8 M 72.1 M 81.3 M 71.6 M 73.7 M 77.4 M 71.8 M 72.2 M 73.1 M 72.7 M 69.9 M 75.4 M 76.7 M 76.6 M 78.9 M 81.7 M 81.7 M 80.9 M 81.3 M 83.2 M 83.2 M 79.6 M 79.6 M 78.3 M 78.3 M 72.7 M 72.3 M 75.4 M 75.5 M 80 M 80.3 M 87.8 M 87.8 M 91 M 91.3 M 92.1 M 92.1 M 94.4 M 90.7 M 96.8 M 96.8 M 92.5 M 89.3 M 92.1 M 92.1 M 96.5 M 88.4 M 86.9 M 86.9 M 87.3 M 77.8 M 83.1 M 83.1 M 83.6 M 74.4 M 68.2 M 68.2 M

Retained Earnings

-555 M -541 M -519 M -520 M -519 M -522 M -518 M -521 M -515 M -505 M -502 M -500 M -500 M -498 M -493 M -489 M -488 M -488 M -488 M -488 M -477 M -481 M -482 M -482 M -484 M -495 M -486 M -486 M -483 M -478 M -474 M -474 M -464 M -460 M -450 M -450 M -440 M -431 M -421 M -421 M -414 M -408 M -395 M -395 M -387 M -377 M -355 M -355 M -341 M -335 M -320 M -320 M -270 M -241 M -216 M -216 M -181 M -171 M -144 M -144 M

Total Assets

448 M 457 M 470 M 484 M 478 M 473 M 469 M 463 M 476 M 477 M 479 M 476 M 469 M 466 M 473 M 469 M 476 M 476 M 480 M 480 M 478 M 465 M 491 M 491 M 479 M 464 M 438 M 438 M 386 M 369 M 379 M 379 M 414 M 394 M 406 M 406 M 415 M 423 M 469 M 469 M 473 M 462 M 467 M 470 M 468 M 460 M 495 M 495 M 485 M 473 M 476 M 476 M 416 M 438 M 473 M 473 M 492 M 500 M 456 M 456 M

Cash and Cash Equivalents

41.3 M 63.3 M 57.4 M 77.8 M 62.6 M 61.1 M 68.6 M 62.2 M 74.5 M 78.7 M 89.4 M 90.8 M 69.2 M 82.4 M 88.7 M 99.3 M 125 M 106 M 118 M 116 M 107 M 90 M 108 M 108 M 96.4 M 80.9 M 76.8 M 76.8 M 59.4 M 68.5 M 83.1 M 83.1 M 79.5 M 67.9 M 72.1 M 72.1 M 69.5 M 83.6 M 120 M 120 M 88.5 M 85.6 M 88.5 M 85.6 M 97.3 M 107 M 97.3 M 107 M 70.4 M 62.4 M 70.4 M 62.4 M 94.8 M 122 M 94.8 M 122 M 148 M 140 M 148 M 140 M

Book Value

53.4 M 61.9 M 81.2 M 49.6 M 47.9 M 45.2 M 45.1 M 41.1 M 47.7 M 50.9 M 53.7 M 54.7 M 51.7 M 47 M 53.2 M 51.6 M 51 M 45.8 M 68.8 M 68.8 M 77.8 M 67.4 M 63.6 M 63.6 M 56 M 41 M 49.9 M 49.9 M 46.1 M 47.1 M 48.6 M 48.6 M 49.1 M 48.6 M 46.5 M 46.5 M 46.7 M 53.4 M 59.7 M 59.7 M 60.9 M 64.1 M 75.8 M 75.8 M 75.9 M 80.5 M 98.5 M 98.5 M 95.2 M 94.7 M 107 M 107 M 151 M 169 M 204 M 204 M 231 M 239 M 240 M 240 M

Total Shareholders Equity

53.4 M 61.9 M 81.2 M 49.6 M 47.9 M 45.2 M 45.1 M 41.1 M 47.7 M 50.9 M 53.7 M 54.7 M 51.7 M 47 M 53.2 M 51.6 M 51 M 45.8 M 68.8 M 45.8 M 77.8 M 77.8 M 77.8 M 67.4 M 56 M 56 M 56 M 41 M 46.1 M 46.1 M 46.1 M 47.1 M 49.1 M 48.6 M 49.1 M 48.6 M 46.7 M 53.4 M 59.7 M 59.7 M 60.9 M 64.1 M 75.8 M 75.8 M 75.9 M 80.5 M 98.5 M 95.8 M 95.2 M 94.7 M 107 M 107 M 151 M 173 M 204 M 196 M 224 M 230 M 240 M 230 M

All numbers in USD currency

Balance Sheet is a fundamental financial report of Accuray Incorporated, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Aethlon Medical Aethlon Medical
AEMD
$ 2.19 3.79 % $ 3.42 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 10.66 2.3 % $ 1.44 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Butterfly Network Butterfly Network
BFLY
$ 4.08 4.09 % $ 864 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 12.79 1.51 % $ 1.92 B usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.36 -0.24 % $ 600 M israelIsrael
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 71.81 2.94 % $ 106 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 36.75 -1.76 % $ 1.14 B usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.69 6.83 % $ 37.6 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 4.12 3.91 % $ 154 M franceFrance
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 64.8 2.08 % $ 1.92 B costa-ricaCosta-rica
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 11.12 0.82 % $ 301 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
FONAR Corporation FONAR Corporation
FONR
$ 18.43 0.08 % $ 121 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.22 1.37 % $ 1.35 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
InMode Ltd. InMode Ltd.
INMD
$ 13.58 1.08 % $ 878 M israelIsrael
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.31 -1.5 % $ 21.1 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 111.67 1.56 % $ 194 B usaUSA
Delcath Systems Delcath Systems
DCTH
$ 9.84 0.31 % $ 352 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 268.33 2.72 % $ 7.57 B usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 9.19 2.0 % $ 708 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 62.26 1.34 % $ 3.4 B britainBritain
AxoGen AxoGen
AXGN
$ 32.83 -0.03 % $ 1.51 B usaUSA
Align Technology Align Technology
ALGN
$ 176.49 4.15 % $ 13.2 B usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 33.53 2.35 % $ 5 K usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 3.77 2.72 % $ 155 M usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 17.17 0.35 % $ 403 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 86.71 3.14 % $ 3.01 B usaUSA
MiMedx Group MiMedx Group
MDXG
$ 4.46 1.02 % $ 659 M usaUSA